icometrix

Company Overview

Founded in 2011, icometrix (Leuven, Belgium; Boston, USA) strives for data-driven insights and personalized patient care, supported by artificial intelligence.

Their solution, icobrain extracts data from brain MRI and CT scans for the radiological reporting and clinical management of neurological disorders such as multiple sclerosis, brain trauma, epilepsy, stroke, dementia, and Alzheimer’s disease. 

icometrix is internationally active and connected to more than 500 clinical practices. In addition, icometrix supports pharmaceutical companies in phase I-III and Real-World Evidence (RWE) studies through imaging and data services, and digital health strategy.

The American Medical Association (AMA) has granted a new CPT Category III code for quantitative brain MRI analysis software. This is only the 5th code of this kind, and the first for brain imaging.

Modalities